Call runs ahead of the accounts: the business management describes is already operating beyond the period it is reportin
The model's full reasoning — Q3 2018 call → NOWe need answer only YES or NO. Need analyze transcript. Need determine if management's own words convey gap between trailing period reported and level business already operating now. Let's parse. Company Agios Q3 2018. Key events: TIBSOVO approved July 2018 and launched, first partial quarter net sales $4.5M. Also IDHIFA won Prix Galien. They announced sNDA for TIBSOVO in newly diagnosed AML not eligible standard therapies, submission by end Jan 2019. AG-881 rights acquired. Mitapivat trials enrollment expected complete 2019. AG-270 dose escalation. AG-636 IND submitted. ASH presentations upcoming. Question: Is there clear gap between trailing period reported and level at which business already operating right now? Management spends call describing company already moved beyond results? Need identify if management treats reported numbers as behind business. The reported period Q3 includes TIBSOVO launch partial quarter. They describe launch progress, 2,000 interactions, 100 prescribers, testing rates. But is that "already busier than print"? The print includes $4.5M sales from launch. They say "first partial quarter of launch" and "pleased with progress." They don't explicitly say current run-rate exceeds reported. They mention "we ended Q3 with reasonable inventory" etc. They discuss future milestones. Need see if management conveys that results understate current state. They might say "we have begun to lay groundwork for next phase" but not necessarily. Let's examine specifics. David: "third quarter ... culminated in achievement of important clinical and regulatory milestones and put us on track to complete remaining milestones... In addition, we began to lay groundwork to support next phase of growth in 2019 and beyond, focused on expanding indications for TIBSOVO, rapidly advancing both cancer and rare genetic disease programs..." This is forward-looking. "Notably, the July approval and launch of TIBSOVO... was a remarkable achievement. We're pleased with progress of U.S. launch and Steve will share additional details." So launch is in period. "With both IDH inhibitors now available... Just last week, IDHIFA won Prix Galien..." That's after period? "Just last week" relative to call, so Q4? But not business. "For TIBSOVO, we know work just begun... Today, we announced two key updates... plan to submit sNDA...
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| YMM | Full Truck Alliance Co. Ltd. | Q2 2022 | 2022-08-25 | C+ |
| BFIN | BankFinancial Corporation | Q1 2022 | 2022-05-06 | A |
| ADSE | ADS-TEC Energy PLC | Q4 2021 | 2022-04-28 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| BFI | BurgerFi International, Inc. | Q3 2021 | 2021-11-12 | C |
BFI · Q3 2021 → YESThe question is whether there's a clear gap between the trailing period being reported (Q3 2021) and the current operating level, as told by management. YES The transcript shows management treating the Q3 results as trailing behind the combined company's current scale. Ian Baines opens by noting the November 3 acquisition closed just days before the call, immediately framing the business as now operating under the combined structure with 61 new locations. Julio Ramirez and Mike Rabinovitch repeatedly reference 2021 developments that occurred after September 30—10 new restaurant openings including one in October, 15 additional Ghost Kitchens, 32 signed leases, and the acquisition itself—as already-real activity driving the current state.
ADSE · Q4 2021 → YESThe question is: Is there a clear gap between the trailing period being reported and the level at which the business is already operating right now, such that management describes a company that has a...YES The transcript shows a clear gap. Management repeatedly frames the company as already operating at a higher level than the 2021 print: a €60 million+ order backlog (explicitly “year-to-date” and “just completed Q1”), U.S. business launched in late 2021 with “initial success … world orders received,” a signed ChargePost contract for 50 units with plans for >10,000 more, U.S. manufacturing plant search already underway with opening expected this year, service contracts expected to start in 2022, and new hires completed.
BFIN · Q1 2022 → YESThe question is whether there's a clear gap between the trailing period being reported (Q1 2022) and the current operating level, as described by management. YES The transcript shows management explicitly updating on April activity as already real and substantial, with loan growth hitting $45 million in April alone (pushing the portfolio over $1.1 billion), Equipment Finance originating more in April than the entire Q1, and overall originations at $148 million in April.